Merck files pill for milder COVID, as AZ showcases its antibody dataAs expected, Merck & Co has moved ahead swiftly with an emergency use application for its oral antiviral Share XMerck files pill for milder COVID, as AZ showcases its antibody datahttps://pharmaphorum.com/news/merck-files-pill-for-milder-covid-as-az-showcases-its-antibody-data/
Scotland backs Cabometyx combo for kidney cancer, amid stalled NICE reviewPatients in Scotland with newly-diagnosed advanced kidney cancer can now access a therapy combining Bristol-Myers Squibb’s immunotherapy Opdivo Share XScotland backs Cabometyx combo for kidney cancer, amid stalled NICE reviewhttps://pharmaphorum.com/news/scotland-backs-cabometyx-combo-for-kidney-cancer-amid-stalled-nice-review/
Flash FDA approval sends ChemoCentryx spiralling upwardsChemoCentryx has claimed FDA approval for its avacopan drug for a rare autoimmune disease, becoming the first orally-active Share XFlash FDA approval sends ChemoCentryx spiralling upwardshttps://pharmaphorum.com/news/flash-fda-approval-sends-chemocentryx-spiralling-upwards/
FDA panel backs Takeda’s CMV drug for transplant patientsTakeda is closing on a first FDA approval in the treatment of refractory cytomegalovirus (CMV) infections in organ Share XFDA panel backs Takeda’s CMV drug for transplant patientshttps://pharmaphorum.com/news/fda-panel-backs-takedas-cmv-drug-for-transplant-patients/
Consternation as NICE rejects Janssen MS drug PonvoryNICE has delivered its first verdict on NHS funding of Janssen’s oral multiple sclerosis drug Ponvory, and it’s Share XConsternation as NICE rejects Janssen MS drug Ponvoryhttps://pharmaphorum.com/news/consternation-as-nice-rejects-janssen-ms-drug-ponvory/
Moderna unveils $500m plan for African vaccine facilityModerna has said it plans to invest $500 million in a new facility for manufacturing mRNA vaccines in Share XModerna unveils $500m plan for African vaccine facilityhttps://pharmaphorum.com/news/moderna-unveils-500m-plan-for-african-vaccine-facility/
J&J joins COVID-19 booster shot drive, filing with FDAJohnson & Johnson’s COVID-19 vaccine has been a minor player in the US vaccination drive so far, but Share XJ&J joins COVID-19 booster shot drive, filing with FDAhttps://pharmaphorum.com/news/jj-joins-covid-19-booster-shot-drive-filing-with-fda/
AZ files for emergency use of COVID-19 antibody combo in USAstraZeneca has sought emergency use authorisation for its antibody combination AZD7442, following trial results indicating it can prevent Share XAZ files for emergency use of COVID-19 antibody combo in UShttps://pharmaphorum.com/news/az-files-for-emergency-use-of-covid-antibody-combo-in-us/
Joy as sickle cell patients get access to Novartis’ Adakveo after NICE rulingPeople living with sickle cell disease (SCD) in England and Wales will be able to get access to Share XJoy as sickle cell patients get access to Novartis’ Adakveo after NICE rulinghttps://pharmaphorum.com/news/joy-as-sickle-cell-patients-get-access-to-novartis-adakveo-after-nice-ruling/
